1-Methylpiperidin-3-amine dihydrochloride → 6-Cyclopropyl-3-(pyrimidin-5-ylamino)-pyrazine-2-carboxylic acid [1-methyl-5-(1-methyl-piperidin-3-ylcarbamoyl)-1H-pyrazol-4-yl]-amide

HRID 2368368ノート

反応式

HRID 2368368 の反応式
[CH:1]1([C:4]2[N:9]=[C:8]([C:10]([NH:12][C:13]3[CH:17]=[N:16][N:15]([CH3:18])[C:14]=3[C:19]([OH:21])=O)=[O:11])[C:7]([NH:22][C:23]3[CH:24]=[N:25][CH:26]=[N:27][CH:28]=3)=[N:6][CH:5]=2)[CH2:3][CH2:2]1.Cl.Cl.[CH3:31][N:32]1[CH2:37][CH2:36][CH2:35][CH:34]([NH2:38])[CH2:33]1>>[CH3:18][N:15]1[C:14]([C:19](=[O:21])[NH:38][CH:34]2[CH2:35][CH2:36][CH2:37][N:32]([CH3:31])[CH2:33]2)=[C:13]([NH:12][C:10]([C:8]2[C:7]([NH:22][C:23]3[CH:28]=[N:27][CH:26]=[N:25][CH:24]=3)=[N:6][CH:5]=[C:4]([CH:1]3[CH2:3][CH2:2]3)[N:9]=2)=[O:11])[CH:17]=[N:16]1

参加物

3

実験手順

The product was obtained starting from 4-{[6-cyclopropyl-3-(pyrimidin-5-ylamino)-pyrazine-2-carbonyl]-amino}-2-methyl-2H-pyrazole-3-carboxylic acid (25 mg, 66 μmol; example 236, step 3) and 1-methyl-piperidin-3-ylamine dihydrochloride (12 mg, 66 μmol) according to the method described in example 64, step 6 after purification by preparative HPLC using an acetonitrile/water gradient as yellow solid (11 mg, 33%).

後処理

  1. customThe product was obtained
  2. customafter purification by preparative HPLC

出典と根拠

ORDレコード
ord-d150d44d8df64178af79a581d41f6490
出典データセット
uspto-grants-2014_04
特許番号
US08703768B2

反応ノート

読み込み中…